Janus Henderson Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $518K | Sell |
16,402
-128,325
| -89% | -$4.05M | ﹤0.01% | 1935 |
|
|
2025
Q1 | $4.8M | Sell |
144,727
-76,336
| -35% | -$2.53M | ﹤0.01% | 897 |
|
|
2024
Q4 | $7.61M | Buy |
221,063
+52,563
| +31% | +$1.81M | ﹤0.01% | 785 |
|
|
2024
Q3 | $6.74M | Sell |
168,500
-9,867
| -6% | -$395K | ﹤0.01% | 783 |
|
|
2024
Q2 | $5.38M | Sell |
178,367
-6,716
| -4% | -$203K | ﹤0.01% | 818 |
|
|
2024
Q1 | $6.21M | Buy |
185,083
+168,434
| +1,012% | +$5.66M | ﹤0.01% | 804 |
|
|
2023
Q4 | $538K | Sell |
16,649
-41
| -0.2% | -$1.32K | ﹤0.01% | 1958 |
|
|
2023
Q3 | $547K | Buy |
16,690
+4
| +0% | +$131 | ﹤0.01% | 1876 |
|
|
2023
Q2 | $587K | Sell |
16,686
-34,691
| -68% | -$1.22M | ﹤0.01% | 1890 |
|
|
2023
Q1 | $1.68M | Sell |
51,377
-1,240,758
| -96% | -$40.5M | ﹤0.01% | 1365 |
|
|
2022
Q4 | $71.2M | Sell |
1,292,135
-1,738,071
| -57% | -$95.8M | 0.05% | 310 |
|
|
2022
Q3 | $134M | Buy |
3,030,206
+1,605,038
| +113% | +$71.1M | 0.05% | 304 |
|
|
2022
Q2 | $69.5M | Sell |
1,425,168
-179,741
| -11% | -$8.77M | 0.05% | 312 |
|
|
2022
Q1 | $78.1M | Buy |
1,604,909
+61,185
| +4% | +$2.98M | 0.04% | 373 |
|
|
2021
Q4 | $65.8M | Buy |
1,543,724
+324,165
| +27% | +$13.8M | 0.03% | 469 |
|
|
2021
Q3 | $46.7M | Sell |
1,219,559
-41,833
| -3% | -$1.6M | 0.02% | 572 |
|
|
2021
Q2 | $35.6M | Buy |
1,261,392
+107,609
| +9% | +$3.04M | 0.02% | 655 |
|
|
2021
Q1 | $38.1M | Buy |
1,153,783
+59,334
| +5% | +$1.96M | 0.02% | 619 |
|
|
2020
Q4 | $39.6M | Buy |
1,094,449
+219,540
| +25% | +$7.94M | 0.02% | 597 |
|
|
2020
Q3 | $29.7M | Buy |
+874,909
| New | +$29.7M | 0.02% | 625 |
|